gliquidone
Sign in to saveGliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class. It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).
Chemical data
- Formula
- C27H33N3O6S
- Molecular weight
- 527.6 g/mol
- IUPAC name
- 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- +527.209
Show 2 more facts
- P366
- medication
via Wikidata · CC0
Article
3 sectionsContents
- Contraindications
- Pharmacokinetics
- References
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class. It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).
==Contraindications== Allergy to sulfonylureas or sulfonamides Diabetes mellitus type 1 Diabetic ketoacidosis Patients that underwent removal of the pancreas Acute porphyria Severe liver disease accompanying with liver insufficiency Several conditions (e.g., infectious diseases or major surgical intervention), when insulin administration is required Pregnancy or breastfeeding